- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/44 - Non-condensed pyridines; Hydrogenated derivatives thereof
Patent holdings for IPC class A61K 31/44
Total number of patents in this class: 7663
10-year publication summary
|
524
|
513
|
494
|
432
|
472
|
447
|
396
|
355
|
341
|
104
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
100 |
| Merck Sharp & Dohme LLC | 3689 |
94 |
| Boehringer Ingelheim International GmbH | 4629 |
93 |
| Merck Sharp & Dohme Corp. | 2247 |
89 |
| Novartis AG | 11238 |
83 |
| The Regents of the University of California | 18943 |
65 |
| F. Hoffmann-La Roche AG | 7958 |
61 |
| Takeda Pharmaceutical Company Limited | 2961 |
56 |
| Merck & Co., Inc. | 607 |
49 |
| Vertex Pharmaceuticals Incorporated | 1581 |
49 |
| Janssen Pharmaceutica N.V. | 3839 |
47 |
| Hoffmann-La Roche Inc. | 3060 |
39 |
| Pfizer Inc. | 3322 |
39 |
| Merck Patent GmbH | 5909 |
38 |
| Chiesi Farmaceutici S.p.A. | 940 |
38 |
| Abbvie Inc. | 1808 |
37 |
| Purdue Pharma L.P. | 519 |
37 |
| AstraZeneca AB | 3042 |
36 |
| Glaxo Group Limited | 4496 |
34 |
| Gilead Sciences, Inc. | 1879 |
34 |
| Other owners | 6545 |